Added to YB: 2019-04-24
Pitch date: 2019-04-24
APVO [bullish]
Aptevo Therapeutics Inc.
-100%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
Market Cap
$2.2M
Pitch Price
$346.4K
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.05
P/E
-0.02
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
APTEVO THERAPEUTICS INC APVO
A summary for this pitch has not been created yet.
Read full article (0 min)